Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Hologic Qdr 4500a

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT02609191Not ApplicableCompletedPrimary

Assessment of Body Composition Via Dual-energy X-ray Absorptiometry Bone Densitometry

NCT02965742Not ApplicableUnknownPrimary

Clinical Evaluation Of An X-Ray Bone Densitometer:Use Of DXA Technology For Precise Assessment Of Human Body Composition

Showing all 2 trials

Research Network

Common Treatments

  • Hologic Qdr 4500a1
  • First Whole Body Exam Using The Stratos Dr1
  • Stratos1
  • Second Whole Body Exam Using The Stratos Dr1
  • Whole Body Exam Using The Discovery A1

Active Sponsors

  • Diagnostic Medical Systems1
  • DMS Apelem1
  • University Hospital, Montpellier1
  • Centre Hospitalier Universitaire de Nīmes1

Top Investigators

Activity Timeline